Giełda Transportu

Najnowsze Informacje ze Świata TSL

Świat

Intas inks pacts with Japanese, Korean firms for biosimilar product

Intas inks pacts with Japanese, Korean firms for biosimilar product

Exclusive licence agreement signed with Meiji, Dong-A ST to commercialise a biosimilar to Ustekinumab


Źródło

22 July 2021, 13:27